SEMA3E and breast carcinoma: Sema3A, sema3D, sema3E and sema3G overexpression in breast cancer cells significantly inhibits the development of tumor in xenograft models and decreases the number of intra-tumor blood vessels, suggesting an anti-angiogenic role of these molecules [112].